These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1981917)

  • 1. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Jolkkonen J; Kosma VM; Soininen H
    Brain Res; 1987 Jan; 402(1):103-8. PubMed ID: 3828777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
    Reinikainen KJ; Riekkinen PJ; Paljärvi L; Soininen H; Helkala EL; Jolkkonen J; Laakso M
    Neurochem Res; 1988 Feb; 13(2):135-46. PubMed ID: 3362291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD; Weinstein DA; Mash DC
    Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
    Kumar U; Patel SC
    Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.